BioMarin Pharmaceutical Inc (BMRN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

105 DIGITAL DRIVE NOVATO, CA 94949

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

Data as of 2021-07-19 08:12:45 -0400
Market Cap14.407 Billion Shares Outstanding182.743 Million Avg 30-day Volume1.11 Million
P/E Ratio18.1205 Dividend Yield EPS4.16
Price/Sales7.81 Debt to Equity1.39 EBITDA-49.204 Million
Price to Book Value3.46 Forward PE-4.13 Enterprise Value14.396 Billion
Total Cash1.087 Billion Current Debt430.035 Million Gross Profit1.311 Billion
BETA0.88809 52-week High/Low131.95 / 71.35 Next Earnings Date2021-07-28 Price to Cash FLow (P/CF) 873.454
Data provided by IEX Cloud
View SEC Filings from BMRN instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 7 -28.57% 4 (0.23%) 5 (0.29%) -20.0%
Funds Holding: 505 518 -2.51% 119 (6.98%) 134 (7.78%) -11.19%
13F shares: 174.731 Million 181.915 Million -3.95% 34.126 Million 40.087 Million -14.87%
% Ownership 96.0961 18.7681 22.0827 -15.01%
New Positions: 74 93 -20.43% 18 27 -33.33%
Increased Positions 174 189 -7.94% 45 47 -4.26%
Closed Positions 82 53 54.72% 31 12 158.33%
Reduced Positions 179 168 6.55% 40 48 -16.67%
Total Calls 1.637 Million 3.958 Million -58.64% 640.895 Thousand 1.407 Million -54.44%
Total Puts 2.484 Million 3.2 Million -22.38% 830.4 Thousand 1.036 Million -19.87%
PUT/CALL Ratio 1.52 0.81 87.65% 1.3 0.74 75.68%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

BioMarin Pharmaceutical Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BMRN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BMRN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

1 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MUELLER BRIAN EVP, CHIEF FINANCIAL OFFICER

  • Officer
 30,781 2021-06-29 7

BIENAIME JEAN JACQUES CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 690,372 2021-06-21 13

MEIER RICHARD A

  • Director
 99,392 2021-05-25 2

LAWLIS V BRYAN

  • Director
 23,970 2021-05-25 3

HERON ELAINE J

  • Director
 72,088 2021-05-25 2

SLAMON DENNIS

  • Director
 28,035 2021-05-25 1

PYOTT DAVID E I

  • Director
 35,860 2021-05-25 2

DERE WILLARD H

  • Director
 18,410 2021-05-25 1

HOMBACH ROBERT J.

  • Director
 21,330 2021-05-25 1

ANDERSON ELIZABETH M

  • Director
 13,910 2021-05-25 1

HO MAYKIN

  • Director
 7,470 2021-05-25 3

DAVIS GEORGE ERIC EVP, GENERAL COUNSEL

  • Officer
 64,108 2021-04-30 4

GUYER CHARLES GREG EVP, CHIEF TECHNICAL OFFICER

  • Officer
 41,695 2021-04-30 2

ACOSTA ANDREA GVP, CHIEF ACCOUNTING OFFICER

  • Officer
 18,122 2021-04-30 3

AJER JEFFREY ROBERT EVP, CHIEF COMMERCIAL OFFICER

  • Officer
 58,250 2021-04-08 7

FUCHS HENRY J PRESIDENT, WORLDWIDE R&D

  • Officer
 106,142 2021-03-22 2

GREY MICHAEL G

  • Director
 42,840 2021-03-05 2

BAFFI ROBERT PRESIDENT, GLOBAL MFG/TECH OPS

  • Officer
 189,020 2020-03-20 0

LEWIS ALAN

  • Director
 25,590 2019-06-04 0

SPIEGELMAN DANIEL K EVP, CHIEF FINANCIAL OFFICER

  • Officer
 47,686 2019-04-30 0

FALBERG KATHRYN E

  • Director
 2,640 2016-07-15 0

LAPALME PIERRE

  • Director
 32,750 2015-06-10 0

YOUNG WILLIAM D

  • Director
 11,875 2015-06-10 0

BATE KENNETH

  • Director
 11,875 2015-06-10 0

WOOD MARK VP, HUMAN RESOURCES

  • Officer
 20,277 2013-05-22 0

ASELAGE STEVE EVP, CHIEF BUSINESS OFFICER

  • Officer
 59,030 2012-07-02 0

COOPER JEFFREY H SVP, CHIEF FINANCIAL OFFICER

  • Officer
 41,089 2012-04-30 0

KLEIN JOSEPH III

  • Director
 35,000 2010-03-08 0

KAKKIS EMIL D CHIEF MEDICAL OFFICER

  • Officer
 44,275 2009-03-02 0

SWIEDLER STUART J SVP, CLINICAL AFFAIRS

  • Officer
 No longer subject to file 2008-07-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ACOSTA ANDREA - Officer GVP, CHIEF ACCOUNTING OFFICER

2021-07-19 20:55:29 -0400 2021-07-16 F 285 $78.84 d 18,122 direct 0.1887 0.1887 2 0.0 1

MUELLER BRIAN - Officer EVP, CHIEF FINANCIAL OFFICER

2021-06-30 20:18:11 -0400 2021-06-29 F 576 $83.46 d 30,781 direct 1.8591 -0.3456 1.8591 2 -1.1441 5

BIENAIME JEAN JACQUES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-06-23 17:04:43 -0400 2021-06-21 M 1,000 $37.46 a 304,839 direct 1.2055 0.1552 1.2055 2 -0.4058 5

BIENAIME JEAN JACQUES - Director - Officer CHIEF EXECUTIVE OFFICER

2021-06-23 17:04:43 -0400 2021-06-21 M 1,000 d 138,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 22:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 21:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 21:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 20:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 20:15:05 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 19:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 19:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 18:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 18:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 17:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 17:15:02 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 16:45:02 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 16:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 15:45:02 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 15:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 14:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 14:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 13:45:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 13:15:03 UTC -0.17 0.25 3700000
BIOMARIN PHARMACEUTICAL INC BMRN 2021-07-23 12:45:03 UTC -0.17 0.25 3700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund BMRN -304.0 shares, $-26657.76 2020-12-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund BMRN -16.0 shares, $-1217.28 2020-09-30 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund BMRN -5469.0 shares, $-423464.67 2021-02-26 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BMRN -7500.0 shares, $-566325.0 2021-03-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund BMRN -309.0 shares, $-23332.59 2021-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF BMRN -3229.0 shares, $-243821.79 2021-03-31 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio BMRN -792.0 shares, $-59803.92 2021-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio BMRN -2800.0 shares, $-211428.0 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund BMRN -653.0 shares, $-49308.03 2021-03-31 N-PORT
AQR Funds- AQR Diversified Arbitrage Fund BMRN -2641.0 shares, $-199421.91 2021-03-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund BMRN -6476.0 shares, $-489002.76 2021-03-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND BMRN -1922.0 shares, $-149762.24 2021-04-30 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund BMRN 4912.0 shares, $-379697.6 2021-05-31 N-PORT

Elevate your investments